Surmodics Revenue 2006-2020 | SRDX

Surmodics revenue from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Surmodics Annual Revenue
(Millions of US $)
2019 $100
2018 $81
2017 $73
2016 $71
2015 $62
2014 $57
2013 $56
2012 $52
2011 $53
2010 $54
2009 $122
2008 $97
2007 $73
2006 $70
2005 $62
Surmodics Quarterly Revenue
(Millions of US $)
2020-03-31 $23
2019-12-31 $23
2019-09-30 $31
2019-06-30 $24
2019-03-31 $23
2018-12-31 $22
2018-09-30 $23
2018-06-30 $22
2018-03-31 $19
2017-12-31 $17
2017-09-30 $20
2017-06-30 $18
2017-03-31 $18
2016-12-31 $18
2016-09-30 $18
2016-06-30 $20
2016-03-31 $17
2015-12-31 $17
2015-09-30 $17
2015-06-30 $16
2015-03-31 $14
2014-12-31 $14
2014-09-30 $15
2014-06-30 $15
2014-03-31 $14
2013-12-31 $14
2013-09-30 $14
2013-06-30 $14
2013-03-31 $14
2012-12-31 $14
2012-09-30 $14
2012-06-30 $14
2012-03-31 $12
2011-12-31 $12
2011-09-30 $14
2011-06-30 $13
2011-03-31 $13
2010-12-31 $13
2010-09-30 $16
2010-06-30 $19
2010-03-31 $18
2009-12-31 $17
2009-09-30 $19
2009-06-30 $18
2009-03-31 $21
2008-12-31 $63
2008-09-30 $23
2008-06-30 $24
2008-03-31 $26
2007-12-31 $24
2007-09-30 $21
2007-06-30 $18
2007-03-31 $17
2006-12-31 $17
2006-09-30 $18
2006-06-30 $18
2006-03-31 $18
2005-12-31 $16
2005-09-30 $16
2005-06-30 $17
2005-03-31 $16
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.575B $0.100B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $158.948B 27.56
Medtronic (MDT) Ireland $136.751B 22.23
Stryker (SYK) United States $77.601B 25.19
Boston Scientific (BSX) United States $54.337B 25.55
Baxter (BAX) United States $45.238B 27.61
Lonza Group Ag (LZAGY) Switzerland $35.887B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.689B 0.00
Terumo (TRUMY) Japan $30.016B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.360B 17.84
ResMed (RMD) United States $23.268B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $19.349B 0.00
Sunny Optical Technology (SNPTF) China $16.329B 0.00
Bio-Rad Laboratories (BIO) United States $13.416B 61.07
Insulet (PODD) United States $11.294B 1118.94
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $9.316B 0.00
Perrigo (PRGO) Ireland $7.580B 13.56
GN STORE NORD (GNNDY) Denmark $7.314B 37.79
Hill-Rom Holdings (HRC) United States $6.978B 19.67
William Demant Holdings (WILYY) Denmark $6.951B 0.00
Quidel (QDEL) United States $6.453B 50.71
Canopy Growth (CGC) Canada $5.792B 0.00
Haemonetics (HAE) United States $4.984B 29.94
ICU Medical (ICUI) United States $4.164B 30.38
GW Pharmaceuticals (GWPH) United Kingdom $3.978B 0.00
Neogen (NEOG) United States $3.873B 65.61
Envista Holdings (NVST) United States $3.718B 0.00
Agios Pharmaceuticals (AGIO) United States $3.490B 0.00
NuVasive (NUVA) United States $3.388B 27.21
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.066B 0.00
National Vision Holdings (EYE) United States $2.552B 44.15
AtriCure (ATRC) United States $2.014B 0.00
TG Therapeutics (TGTX) United States $2.014B 0.00
Cardiovascular Systems (CSII) United States $1.464B 0.00
Aurora Cannabis (ACB) Canada $1.418B 0.00
Aphria (APHA) Canada $1.173B 0.00
NanoString Technologies (NSTG) United States $1.151B 0.00
Phibro Animal Health (PAHC) United States $1.108B 22.08
InMode (INMD) Israel $1.084B 22.91
MacroGenics (MGNX) United States $0.981B 0.00
Cerus (CERS) United States $0.968B 0.00
PetIQ (PETQ) United States $0.860B 24.84
Omeros (OMER) United States $0.799B 0.00
Quanterix (QTRX) United States $0.735B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.725B 122.69
Zynex (ZYXI) United States $0.711B 71.43
VAREX IMAGING (VREX) United States $0.691B 17.17
Eagle Pharmaceuticals (EGRX) United States $0.677B 48.51
Meridian Bioscience (VIVO) United States $0.677B 25.48
Vapotherm (VAPO) United States $0.644B 0.00
OraSure Technologies (OSUR) United States $0.641B 129.19
Lantheus Holdings (LNTH) United States $0.581B 11.69
LeMaitre Vascular (LMAT) United States $0.569B 32.44
Owens & Minor (OMI) United States $0.497B 13.15
BioLife Solutions (BLFS) United States $0.429B 150.00
Repro-Med Systems (KRMD) United States $0.413B 347.00
Utah Medical Products (UTMD) United States $0.387B 28.12
Viemed Healthcare (VMD) United States $0.332B 29.76
HEXO (HEXO) $0.329B 0.00
Cytosorbents (CTSO) United States $0.318B 0.00
Organigram Holdings (OGI) Canada $0.309B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.298B 0.00
InfuSystems Holdings (INFU) United States $0.236B 130.78
Female Health (VERU) United States $0.233B 0.00
Chimerix (CMRX) United States $0.198B 0.00
Evolus (EOLS) United States $0.184B 0.00
Bovie Medical (APYX) United States $0.168B 0.00
Fonar (FONR) United States $0.162B 14.40
Exagen (XGN) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.145B 0.00
Chembio Diagnostics (CEMI) United States $0.144B 0.00
Liberty Health Sciences (LHSIF) Canada $0.137B 0.00
Surface Oncology (SURF) United States $0.133B 0.00
United Health Products (UEEC) United States $0.130B 0.00
MTech Acquisition (KERN) United States $0.121B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.102B 0.00
Wound Management Technologies (SMTI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
United-Guardian (UG) United States $0.076B 17.62
Brainsway (BWAY) Israel $0.075B 0.00
Nephros (NEPH) United States $0.071B 0.00
Capricor Therapeutics (CAPR) United States $0.061B 0.00
GUARDION HEALTH (GHSI) United States $0.042B 0.00
FSD PHARMA INC (HUGE) Canada $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
NF Energy Saving (BIMI) China $0.027B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.015B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00